Regen BioPharma Issues End of Fiscal Year Shareholder Letter

Regen BioPharma Inc. (OTCQB: RGBP) and (OTCQB: RGBPP) President Dr. Harry Lander issued the following fiscal year end shareholder letter: As the end of Regen’s fiscal year 2017 approaches on September 30th, I would like to summarize our progress during the past twelve months and look to the future.